Pay in 4 interest-free payments of $27.23 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
InChi: InChI=1S/C19H20ClN3
and thereby prolonged action potential durations (APDs) and corrected QT interval (QTc) intervals
InChiKey: GRRNUXAQVGOGFE-HUCHGKBZSA-N
GPR120-IN-1
Emricasan Catalog No.:M10978-10 InChi: InChI=1S/C19H20ClN3Emricasan, also known as IDN 6556 and PF 03491390, is a first in class caspase inhibitor in clinical trials for the treatment of liver diseases. Emricasan (IDN 6556) decreases liver injury and fibrosis in a murine model of non alcoholic steatohepatitis. IDN6556 facilitates marginal mass islet engraftment in a porcine islet autotransplant model. Oral IDN 6556 may lower aminotransferase activity in patients with chronic hepatitis C. Orally administered
US$ 22.00
US$ 16.00
US$ 16.00
US$ 20.00